PFM Health Sciences’s iRhythm Holdings IRTC Stock Holding History

PFM Health Sciences’s Portfolio IRTC Stock Details IRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,000	Closed	-$2.09M	–	80
2023 Q2	$2.09M	Buy	+20,000	New	+$2.4M	0.08%	77

Other funds holding IRTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFM Health Sciences's IRTC Position: Q4 2025 in Review

PFM Health Sciences sold out of iRhythm Holdings (IRTC) in Q4 2025, closing a stake of 64,998 shares — an estimated $11.2M sold.

PFM Health Sciences first reported a position in IRTC in Q2 2018 and held it in 21 quarters. The position peaked at $80.1M in Q3 2019. 334 funds tracked by Wall St. Rank hold IRTC as of Q4 2025.

PFM Health Sciences reported no remaining iRhythm Holdings position as of Q4 2025 after selling out during the quarter.
PFM Health Sciences sold 64,998 iRhythm Holdings shares in Q4 2025, an estimated $11.2M.
PFM Health Sciences first reported a position in iRhythm Holdings in Q2 2018 and held it in 21 quarters.
PFM Health Sciences's iRhythm Holdings position peaked at $80.1M in Q3 2019.
334 funds tracked by Wall St. Rank held iRhythm Holdings as of Q4 2025.

Based on PFM Health Sciences's 13F filing for Q4 2025, filed 17 Feb 2026.